Skip to main content

Table 3 Fatty acid composition on admission and after 3 months of treatment

From: Very long chain fatty acids are an important marker of nutritional status in patients with anorexia nervosa: a case control study

 

AN-R (n=38)

AN-BP (n=31)

Control group

on admission

after 3 months

on admission

after 3 months

(n = 25)

C12:0 (μg/ml)

2.62 ± 1.98

3.10 ± 1.41

3.82 ± 3.17

3.84 ± 3.19

3.66 ± 4.16

C14:0 (μg/ml)

16.12 ± 5.59

25.58 ± 7.04∗†

21.78 ± 8.85∗

29.89 ± 13.75∗

15.48 ± 6.20

C14:1n-5 (μg/ml)

1.42 ± 0.71

2.15 ± 0.87∗†

2.27 ± 1.27∗

3.01 ± 1.58∗

1.29 ± 0.65

C16:0 (μg/ml)

488.11 ± 162.94

493.89 ± 93.78

603.93 ± 156.37∗

537.83 ± 130.01

457.96 ± 70.72

C16:1n-7 (μg/ml)

42.55 ± 23.35

46.47 ± 19.09

83.35 ± 44.26∗

55.39 ± 35.42†

35.64 ± 11.76

C18:0 (μg/ml)

231.11 ± 49.62

243.47 ± 39.59

274.06 ± 63.23∗

263.44 ± 41.13

232.80 ± 39.22

C18:1n-9 (μg/ml)

523.11 ± 253.63

406.00 ± 68.07

721.10 ± 209.79∗

458.22 ± 126.84†

461.12 ± 100.02

C18:2n-6 (μg/ml)

794.34 ± 217.25

736.31 ± 170.57

973.61 ± 286.45∗

851.22 ± 173.29

820.48 ± 160.14

C18:3n-6 (μg/ml)

5.71 ± 4.90

8.71 ± 5.44

8.40 ± 5.67

9.94 ± 5.17∗

6.11 ± 3.32

C18:3n-3 (μg/ml)

20.48 ± 8.39∗

22.95 ± 7.01∗

24.86 ± 8.53∗

25.78 ± 10.44∗

15.72 ± 5.57

C20:0 (μg/ml)

2.04 ± 0.57∗

1.83 ± 0.41

2.15 ± 0.66∗

1.82 ± 0.39

1.56 ± 0.29

C20:1n-9 (μg/ml)

6.07 ± 2.40∗

5.54 ± 2.64

5.89 ± 2.19∗

6.57 ± 3.5∗

4.26 ± 0.86

C20:2n-6 (μg/ml)

5.71 ± 3.25

5.83 ± 1.39∗

6.87 ± 3.78∗

7.26 ± 2.01∗

4.69 ± 1.26

C20:3n-9 (μg/ml)

1.29 ± 1.45

1.15 ± 0.30

1.50 ± 0.68

1.54 ± 0.86

1.36 ± 0.37

C20:3n-6 (μg/ml)

21.36 ± 10.65

29.78 ± 10.06†

29.06 ± 17.47

37.00 ± 16.44∗†

24.06 ± 8.59

C20:4n-6 (μg/ml)

163.21 ± 62.70

132.47 ± 40.96∗

175.06 ± 61.08

151.33 ± 42.28

183.84 ± 47.08

C20:5n-3 (μg/ml)

60.09 ± 44.89∗

86.89 ± 30.13∗†

40.98 ± 28.97

75.94 ± 30.24∗†

36.08 ± 22.78

C22:0 (μg/ml)

1.54 ± 0.77∗

1.66 ± 1.06∗

1.46 ± 0.86∗

1.75 ± 0.97∗

0.90 ± 0.42

C22:1n-9 (μg/ml)

2.63 ± 0.98∗

2.62 ± 2.20

2.72 ± 1.21∗

2.99 ± 2.23

1.76 ± 0.65

C22:5n-3 (μg/ml)

17.82 ± 6.60

25.37 ± 6.26∗†

19.06 ± 5.95∗

25.44 ± 8.23∗†

15.73 ± 3.24

C22:6n-3 (μg/ml)

98.26 ± 44.55

114.63 ± 44.99†

96.71 ± 41.14

100.11 ± 38.07

84.92 ± 27.89

C24:0 (μg/ml)

1.46 ± 0.56∗

1.42 ± 0.57∗

1.62 ± 0.65∗

1.58 ± 8.25∗

0.96 ± 0.28

C24:1n-9 (μg/ml)

2.41 ± 1.58

1.90 ± 1.32

2.42 ± 1.59

2.33 ± 8.26

1.60 ± 0.47

C22:4n-6 (μg/ml)

3.86 ± 2.07

3.42 ± 1.19

4.71 ± 1.71∗

4.33 ± 2.07

3.72 ± 0.92

Total (μg/ml)

2515.84 ± 703.48

2401.55 ± 347.34

3096.36 ± 716.48∗

2658.56 ± 8.27

2417.48 ± 363.46

  1. AN-R Anorexia Nervosa Restricting type, AN-BP Anorexia Nervosa Binge-Eating/Purging type
  2. Values presented as the mean ± SD for the number of observations indicated
  3. Significant differences in the comparisons of the AN-R and AN-BP groups with controls: ∗P < 0.05
  4. Significant differences between values on admission and after 3 months: †P < 0.05
Back to article page

BioPsychoSocial Medicine

ISSN: 1751-0759

Contact us